Influence of Body Mass Index on Presence of Disseminated Tumor Cells in Clinical Stage I-III Breast CancerLodhi, ABhattacharyya, AKrishnamurthy, SHall, CAnderson, ASingh, BLucci, A
Patients with high-risk, early breast cancer receiving adjuvant abemaciclib maintained benefit with the agent regardless of dose modification. Same-Day Dosing of Eflapegrastim and Chemotherapy Is Safe, Reduces Duration of Severe Neutropenia in Early-Stage Breast Cancer By Ashley Chan March 9th 2025...
Coffee Talk™: Navigating the Impact of HER2/3, TROP2, and PARP from Early Stage to Advanced Breast Cancer Care View More BURST CME™: Illuminating the Crossroads of Precision Medicine and Targeted Treatment Options in Metastatic CRC View More Fighting Disparities and Saving Lives: An Explo...
Recent clinical trials of adjuvant therapy for early stage breast cancer support two general observations. First, overall survival is not impacted by the extent of surgery. Low rates of axillary relapse in patients treated with total mastectomy alone combined with the availability of systemic therapy ...
Studies have different requirements for volunteers. The research team may be looking for people of a certain age or at a certain cancer stage. If you meet the qualifications, here’s what you can expect: You’ll be officially enrolled in the study after giving what’s called informed consent...
Ten-year multi-institutional results of breast-conserving surgery and radiotherapy in BRCA1/2-associated stage I/II breast cancer J Clin Oncol, 24 (2006), pp. 2437-2443 View in ScopusGoogle Scholar 12. N. Andrieu, D. Goldgar, D. Easton, et al. Pregnancies, breast-feeding, and breast ...
The thought-provoking SONIA trial showed that patients with hormone receptor-positive, HER2-negative advanced-stage breast cancer receiving deferred (second-line) versus first-line cyclin dependent-kinase (CDK) 4/6 inhibitors have noninferior progression-free survival after second-line treatment; such ...
Race and Breast Cancer Breaking Barriers Building Equity in Research Michelle Anderson-Benjamin, a wife and mom of two, noticed back pain and a discharge from her right nipple during the pandemic. She went straight to her doctor, who ordered a mammogram. It was stage I triple-negative breast...
(1 mg/day) treatment showed promising antitumor activity in a two-stage phase II study (NCT02034916), with manageable adverse effects for gBRCA-mutated progressive breast cancer subjects who had previously undergone platinum-based or non-platinum chemotherapy [54]. In an open-label, randomized, ...
The current diagnostic technologies for assessing the axillary lymph node metastasis (ALNM) status accurately in breast cancer (BC) remain unsatisfactory. Here, we developed a diagnostic model for evaluating the ALNM status using a combination of mRNAs and the T stage of the primary tumor as a ...